The Breast Blog: Canadian Breast Cancer Network
Canadian Breast Cancer Network (CBCN) Teleconference and WebCast:
"Breast Cancer Update: Latest Data As Presented At ASCO 2005"
Tuesday, May 24, 2005. 7-8:30pm EST
Presentation by Dr Clemons will include information about:
--The Arimidex™, Tamoxifen Alone or in Combination (ATAC) Trial
--Extended Adjuvant Treatment in Breast Cancer and the ABCSG-6a Trial
--Skeletal health in postmenopausal survivors of EBC
--ZoladexTM and ArimidexTM in premenopausal women with hormone receptor positive breast cancer
The American Society of Clinical Oncology (ASCO) is hosting their annual meeting from May 13-17, 2005. This is the largest oncology meeting in the world and is considered to be the premier educational and scientific event in the oncology community. As a result, a great deal of significant data relating to breast cancer research and treatment is released annually at ASCO.
As a service to our members, the Canadian Breast Cancer Network (CBCN) is hosting a teleconference and webcast on Tuesday, May 24, 2005, from 7:00–8:30 pm EST, entitled "Breast Cancer Update: Latest data as presented at ASCO 2005". During this teleconference and webcast, a leading Canadian medical oncologist will walk through the latest data to help our members better understand the findings from ASCO 2005.
This teleconference and webcast is free of charge, sponsored through an unrestricted educational grant from AstraZeneca Canada. To register, please call 1-866-590-0914 or email email@example.com. After you have registered, you will be informed about how to take part and how to submit your questions – if you have any specific to ASCO - in advance of the call. Registration is limited to those residing in Canada and is by invitation only.
If you have any questions, please do not hesitate to contact us at firstname.lastname@example.org or call 1-416-815-9100